Clinical trial
A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously…
NCT00424047 · Celgene, Industry · Completed
Key facts
| NCT number | NCT00424047 |
|---|---|
| Title | A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma |
| Official title | The Official Title is A Multi-center, Randomized, Parallel-group, Double-blind, Placebo Controlled Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma. |
| Lead sponsor | Celgene, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | CC-5013 plus dexamethasone, Dexamethasone plus Placebo |
| Enrollment | 351 |
| Start date | Jan 1, 2003 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 12, 2013 |
| First posted | Jan 18, 2007 |
| Last update posted | Oct 19, 2017 |
| Countries | Australia, Austria, Belgium, France, Germany, Greece, Ireland, Israel, Italy, Poland, Spain, Sweden and 3 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: